Scientific Studies About CBD Oil
Pain:
A Double-blind, Randomized, Placebo-controlled, Parallel-group Study of THC/CBD Oromucosal Spray in Combination With the Existing Treatment Regimen, in the Relief of Central Neuropathic Pain in Patients With Multiple Sclerosis
Cannabinoids in the Management of Difficult to Treat Pain
An Open-label Extension Study to Investigate the Long-term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal Thc Spray in Patients With Terminal Cancer-related Pain Refractory to Strong Opioid Analgesics
Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes
Pain Relief with Cannabinoids: the Importance of Endocannabinoids and Cannabinoids for Therapy
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients With Intractable Cancer-related Pain
Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats
Cannabidiol – Delta9-Tetrahydrocannabinol Interactions on Acute Pain and Locomotor Activity
Non-psychoactive Cannabinoids Modulate the Descending Pathway of Antinociception in Anaesthetized Rats Through Several Mechanisms of Action
Cannabinoids Suppress Inflammatory and Neuropathic Pain by Targeting Α3 Glycine Receptors
Meta-analysis of Cannabis Based Treatments for Neuropathic and Multiple Sclerosis-related Pain
Sativex: Clinical Efficacy and Tolerability in the Treatment of Symptoms of Multiple Sclerosis and Neuropathic Pain
Cannabinoids for Neuropathic Pain
Neuropathic Orofacial Pain: Cannabinoids as a Therapeutic Avenue
Oromucosal Delta9-tetrahydrocannabinol/cannabidiol for Neuropathic Pain Associated With Multiple Sclerosis: an Uncontrolled, Open-label, 2-year Extension Trial
The Non-psychoactive Cannabis Constituent Cannabidiol Is an Orally Effective Therapeutic Agent in Rat Chronic Inflammatory and Neuropathic Pain
Vanilloid TRPV1 Receptor Mediates The Antihyperalgesic Effect Of The Nonpsychoactive Cannabinoid, Cannabidiol, In A Rat Model Of Acute Inflammation
Cannabidiol Inhibits Paclitaxel-induced Neuropathic Pain Through 5-HT1A) Receptors Without Diminishing Nervous System Function or Chemotherapy Efficacy
Sativex Successfully Treats Neuropathic Pain Characterised by Allodynia: a Randomised, Double-blind, Placebo-controlled Clinical Trial
Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex, a Cannabis-based Medicine
Anxiety:
Neural Basis of Anxiolytic Effects of Cannabidiol (CBD) in Generalized Social Anxiety Disorder: a Preliminary Report
Antidepressant-like and Anxiolytic-like Effects of Cannabidiol: a Chemical Compound of Cannabis Sativa
Cannabidiol as a Potential Treatment for Anxiety Disorders
Cannabidiol, a Cannabis Sativa Constituent, as an Anxiolytic Drug
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-naive Social Phobia Patients
Central Anandamide Deficiency Predicts Stress-induced Anxiety: Behavioral Reversal Through Endocannabinoid Augmentation
The Anxiolytic Effect of Cannabidiol on Chronically Stressed Mice Depends on Hippocampal Neurogenesis: Involvement of the Endocannabinoid System
Cannabidiol Regulation of Emotion and Emotional Memory Processing: Relevance for Treating Anxiety-related and Substance Abuse Disorders
Effects of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report
Effect of Prior Foot Shock Stress and Delta9-Tetrahydrocannabinol, Cannabidiolic Acid, and Cannabidiol on Anxiety-like Responding in the Light-dark Emergence Test in Rats
A Systematic Review of Plant-Derived Natural Compounds for Anxiety Disorders
Plant-based Medicines for Anxiety Disorders, Part 2: a Review of Clinical Studies With Supporting Preclinical Evidence
Cannabidiol Does Not Dampen Responses to Emotional Stimuli in Healthy Adults
Epilepsy:
Cannabidiol: Antiepileptic Drug Comparisons and Interactions in Experimentally Induced Seizures in Rats
Report of a Parent Survey of Cannabidiol-enriched Cannabis Use in Pediatric Treatment-resistant Epilepsy
The Role of Potassium Bk Channels in Anticonvulsant Effect of Cannabidiol in Pentylenetetrazole and Maximal Electroshock Models of Seizure in Mice
Cannabidiol Exerts Anti-convulsant Effects in Animal Models of Temporal Lobe and Partial Seizures
Cannabidiol Displays Anti-epileptiform and Antiseizure Properties in Vitro and in Vivo
Report of a Parent Survey of Cannabidiol-enriched Cannabis Use in Pediatric Treatment-resistant Epilepsy
Cannabis, Cannabidiol, and Epilepsy: from Receptors to Clinical Response
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability
Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy?
Therapeutic Effects of Cannabinoids in Animal Models of Seizures, Epilepsy, Epileptogenesis, and Epilepsy-related Neuroprotection
Pharmacology of Cannabinoids in the Treatment of Epilepsy
Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure
The Cannabinoids as Potential Antiepileptics
Hypnotic and Antiepileptic Effects of Cannabidiol
Cannabidiol Exerts Anti-convulsant Effects in Animal Models of Temporal Lobe and Partial Seizures
Cannabidivarin (cbdv) Suppresses Pentylenetetrazole (ptz)-induced Increases in Epilepsy-related Gene Expression
Seizing an Opportunity for the Endocannabinoid System
Endocannabinoid System Protects Against Cryptogenic Seizures
Arthritis:
Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress
Therapeutic Potential of Cannabinoid-based Drugs
Oral Anti-inflammatory Activity of Cannabidiol, a Non-psychoactive Constituent of Cannabis, in Acute Carrageenan-induced Inflammation in the Rat Paw
The Abnormal Cannabidiol Analogue O-1602 Reduces Nociception in a Rat Model of Acute Arthritis Via the Putative Cannabinoid Receptor GPR55
Preliminary Assessment of the Efficacy, Tolerability and Safety of a Cannabis-based Medicine (Sativex) in the Treatment of Pain Caused by Rheumatoid Arthritis
The Nonpsychoactive Cannabis Constituent Cannabidiol Is an Oral Anti-arthritic Therapeutic in Murine Collagen-induced Arthritis
Involvement of the Endocannabinoid System in Osteoarthritis Pain
Attenuation of Early Phase Inflammation by Cannabidiol Prevents Pain and Nerve Damage in Rat Osteoarthritis
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma-associated Herpesvirus-infected Endothelium
Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22phox and Nox4 Expression
Triggering of the Trpv2 Channel by Cannabidiol Sensitizes Glioblastoma Cells to Cytotoxic Chemotherapeutic Agents
Cannabis and Cannabinoids (PDQ®)–Health Professional Version
Cannabidiol as Potential Anticancer Drug
A Comparative Study on Cannabidiol-induced Apoptosis in Murine Thymocytes and El-4 Thymoma Cells
Cannabidiol-induced Apoptosis in Human Leukemia Cells: a Novel Role of Cannabidiol in the Regulation of P22phox and Nox4 Expression
Cannabidiol Inhibits Lung Cancer Cell Invasion and Metastasis Via Intercellular Adhesion Molecule-1
Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study of the Efficacy, Safety, and Tolerability of Thc:cbd Extract and Thc Extract in Patients With Intractable Cancer-related Pain
Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent
Anticancer Activity of Anandamide in Human Cutaneous Melanoma Cells
Diabetes:
Cannabidiol Lowers Incidence of Diabetes in Non-obese Diabetic Mice
Neuroprotective and Blood-retinal Barrier-preserving Effects of Cannabidiol in Experimental Diabetes
Cannabinoids Alter Endothelial Function in the Zucker Rat Model of Type 2 Diabetes
Cannabidiol Arrests Onset of Autoimmune Diabetes in NOD Mice
Activation of the Peripheral Endocannabinoid System in Human Obesity
The Endocannabinoid System and Plant-derived Cannabinoids in Diabetes and Diabetic Complications
Cannabidiol Protects Retinal Neurons by Preserving Glutamine Synthetase Activity in Diabetes
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and β-Pancreatic Cells and in Obesity and Hyperglycemia
Endocannabinoids and the Control of Energy Homeostasis
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
Biochemical and Immunohistochemical Changes in Delta-9-tetrahydrocannabinol-treated Type 2 Diabetic Rats
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
Diabetic Retinopathy: Role of Inflammation and Potential Therapies for Anti-Inflammation
The Endocannabinoid System in Obesity and Type 2 Diabetes
Cannabinoid-mediated Modulation of Neuropathic Pain and Microglial Accumulation in a Model of Murine Type I Diabetic Peripheral Neuropathic Pain
The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults
Nausea:
Cannabidiol, a Non-psychotropic Component of Cannabis, Attenuates Vomiting and Nausea-like Behaviour Via Indirect Agonism of 5-HT(1A) Somatodendritic Autoreceptors in the Dorsal Raphe Nucleus
Regulation of Nausea and Vomiting by Cannabinoids
The Effects of Cannabidiol and Tetrahydrocannabinol on Motion-induced Emesis in Suncus Murinus
Regulation of Nausea and Vomiting by Cannabinoids and the Endocannabinoid System
Preliminary Efficacy and Safety of an Oromucosal Standardized Cannabis Extract in Chemotherapy-induced Nausea and Vomiting
Suppression of Lithium Chloride-induced Conditioned Gaping (a Model of Nausea-induced Behaviour) in Rats (using the Taste Reactivity Test) With Metoclopramide Is Enhanced by Cannabidiolic Acid
The Prevalence and Incidence of Medicinal Cannabis on Prescription in the Netherlands
Interaction Between Non-psychotropic Cannabinoids in Marihuana: Effect of Cannabigerol (CBG) on the Anti-nausea or Anti-emetic Effects of Cannabidiol (CBD) in Rats and Shrews
Cannabidiol, a Non-psychoactive Component of Cannabis and Its Synthetic Dimethylheptyl Homolog Suppress Nausea in an Experimental Model With Rats
Effect of Combined Oral Doses of Δ(9)-tetrahydrocannabinol (THC) and Cannabidiolic Acid (CBDA) on Acute and Anticipatory Nausea in Rat Models
Cannabidiolic Acid Prevents Vomiting in Suncus Murinus and Nausea-induced Behaviour in Rats by Enhancing 5-HT1A Receptor Activation
Psychosis:
Cannabis Drug Shows Promise in Treating Schizophrenia
Cannabidiol, a Cannabis Sativa Constituent, as an Antipsychotic Drug
Cannabidiol as a Potential Treatment for Psychosis
Medical use of Cannabis. Cannabidiol: a New Light for Schizophrenia?
Cannabinoids and Schizophrenia: Therapeutic Prospects
Cannabidiol Monotherapy for Treatment-Resistant Schizophrenia
Marijuana Compound Treats Schizophrenia with Fewer Side Effects: Clinical Trial
Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model
Cannabidiol Enhances Anandamide Signaling and Alleviates Psychotic Symptoms of Schizophrenia
A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of Translational Investigation
Cannabis with High Cannabidiol Content is Associated with Fewer Psychotic Experiences
Neuronal and Molecular Effects of Cannabidiol on the Mesolimbic Dopamine System: Implications for Novel Schizophrenia Treatments
Antipsychotic-like Effects of Cannabidiol and Rimonabant: Systematic Review of Animal Studies
Clearing the Smoke: What do We Know About Adolescent Cannabis Use and Schizophrenia?
Peripheral Endocannabinoid System Dysregulation in First-episode Psychosis
Study: Cannabidiol Holds Promise for Treating Psychosis
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Delta9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia
Potential Protective Effects of Cannabidiol on Neuroanatomical Alterations in Cannabis Users and Psychosis: a Critical Review